OBJECTIVES: To examine increased notifications of hepatitis C virus (HCV) in men who have sex with men (MSM) infected with HIV in Victoria, and evaluate HCV transmission risk factors other than injecting drug use. DESIGN, SETTING AND PARTICIPANTS: Case series through retrospective review of all HCV cases in Victoria from 1 April 2010 to 30 June 2011, with clinical and laboratory data examined in likely MSM to identify a co-infected cohort. Patients with newly acquired HCV with HIV co-infection were invited to complete a questionnaire exploring novel risk factors for HCV transmission (non-injecting drug use, sexual practices with increased likelihood of trauma, and presence of genital ulcers). Sequencing was performed to determine the local molecular epidemiology of HCV co-infection. MAIN OUTCOME MEASURES: Demographics of newly co-infected MSM, traditional versus novel risk factors for HCV acquisition, prior knowledge of potential for sexual transmission of HCV, and association between viral sequences. RESULTS: Thirty-one patients with HIV were identified from 3365 notifications of hepatitis C. The median age was 42 years, and median time from HIV to HCV diagnosis was 22 months. Most patients were asymptomatic, with abnormal liver function tests prompting HCV testing. Interviews with 14 patients identified a high prevalence of novel risk factors and limited knowledge of HCV risk. Two clusters of matching viral sequences were identified. CONCLUSIONS: Novel HCV transmission routes have emerged in Victoria. These data reinforce the need for targeted testing and prevention strategies among HIV-infected MSM.
OBJECTIVES: To examine increased notifications of hepatitis C virus (HCV) in men who have sex with men (MSM) infected with HIV in Victoria, and evaluate HCV transmission risk factors other than injecting drug use. DESIGN, SETTING AND PARTICIPANTS: Case series through retrospective review of all HCV cases in Victoria from 1 April 2010 to 30 June 2011, with clinical and laboratory data examined in likely MSM to identify a co-infected cohort. Patients with newly acquired HCV with HIV co-infection were invited to complete a questionnaire exploring novel risk factors for HCV transmission (non-injecting drug use, sexual practices with increased likelihood of trauma, and presence of genital ulcers). Sequencing was performed to determine the local molecular epidemiology of HCV co-infection. MAIN OUTCOME MEASURES: Demographics of newly co-infected MSM, traditional versus novel risk factors for HCV acquisition, prior knowledge of potential for sexual transmission of HCV, and association between viral sequences. RESULTS: Thirty-one patients with HIV were identified from 3365 notifications of hepatitis C. The median age was 42 years, and median time from HIV to HCV diagnosis was 22 months. Most patients were asymptomatic, with abnormal liver function tests prompting HCV testing. Interviews with 14 patients identified a high prevalence of novel risk factors and limited knowledge of HCV risk. Two clusters of matching viral sequences were identified. CONCLUSIONS: Novel HCV transmission routes have emerged in Victoria. These data reinforce the need for targeted testing and prevention strategies among HIV-infected MSM.
Authors: Sofia R Bartlett; Brendan Jacka; Rowena A Bull; Fabio Luciani; Gail V Matthews; Francois M J Lamoury; Margaret E Hellard; Behzad Hajarizadeh; Suzy Teutsch; Bethany White; Lisa Maher; Gregory J Dore; Andrew R Lloyd; Jason Grebely; Tanya L Applegate Journal: Infect Genet Evol Date: 2015-11-26 Impact factor: 3.342
Authors: Nick Scott; Mark Stoové; David P Wilson; Olivia Keiser; Carol El-Hayek; Joseph Doyle; Margaret Hellard Journal: J Int AIDS Soc Date: 2018-01 Impact factor: 5.396
Authors: Sophia E Schroeder; Peter Higgs; Rebecca Winter; Graham Brown; Alisa Pedrana; Margaret Hellard; Joseph Doyle; Mark Stoové Journal: J Int AIDS Soc Date: 2019-05 Impact factor: 5.396
Authors: Gaby S Steba; Sylvie M Koekkoek; Michael W T Tanck; Joost W Vanhommerig; Jan T M van der Meer; David Kwa; Kees Brinkman; Maria Prins; Ben Berkhout; Georgios Pollakis; Richard Molenkamp; Janke Schinkel; William A Paxton Journal: Liver Int Date: 2018-10-17 Impact factor: 5.828
Authors: Sofia R Bartlett; Andrey Verich; Joanne Carson; Samira Hosseini-Hooshyar; Phillip Read; David Baker; Jeffrey J Post; Robert Finlayson; Mark Bloch; Joseph S Doyle; David Shaw; Margaret Hellard; Maria Martinez; Philippa Marks; Gregory J Dore; Gail V Matthews; Tanya Applegate; Marianne Martinello Journal: Health Sci Rep Date: 2022-08-18
Authors: Parastu Kasaie; Barun Mathema; W David Kelton; Andrew S Azman; Jeff Pennington; David W Dowdy Journal: PLoS One Date: 2015-12-17 Impact factor: 3.240
Authors: Rachel Sacks-Davis; Joseph S Doyle; Andri Rauch; Charles Beguelin; Alisa E Pedrana; Gail V Matthews; Maria Prins; Marc van der Valk; Marina B Klein; Sahar Saeed; Karine Lacombe; Nikoloz Chkhartishvili; Frederick L Altice; Margaret E Hellard Journal: J Int AIDS Soc Date: 2018-04 Impact factor: 5.396